The Senate's war funding bill did not include a House-approved provision to ban deals in which brand-name drug makers pay generics manufacturers to keep competitive products off the market.
Published in Brief:
|Health Economics & Reimbursement Manager - Transcatheter Heart Valve||
|Sr. Medical Device Reimbursement Specialist - Regional||
|Fort Worth , TX|
|Assistant General Counsel/Senior Corporate Counsel - Healthcare Law Group||
|Clinical Trials Agreements Specialist (209955)||
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
|SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST||
Matheson Tri-Gas, Inc.